Hedge Fund - Callodine Capital Management
Glaxosmithkline Plc (GSK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $22,081,800 | 3.67% | 570,000 | $36.61 |
| 2 | 2024 - Q4 (2024-12-31) | $23,674,000 | 4.88% | 700,000 | $36.00 |
| 3 | 2024 - Q3 (2024-09-30) | $24,732,400 | 5.15% | 605,000 | $40.91 |
| 4 | 2024 - Q2 (2024-06-30) | $20,790,000 | 4.84% | 540,000 | $42.07 |
| 5 | 2024 - Q1 (2024-03-31) | $17,148,000 | 4.14% | 400,000 | $41.24 |
| 6 | 2023 - Q4 (2023-12-31) | $16,677,000 | 4.39% | 450,000 | $35.90 |
| 7 | 2023 - Q3 (2023-09-30) | $17,218,750 | 4.79% | 475,000 | $35.49 |
| 8 | 2023 - Q2 (2023-06-30) | $16,038,000 | 4.6% | 450,000 | $35.87 |
| 9 | 2023 - Q1 (2023-03-31) | $16,011,000 | 4.72% | 450,000 | $34.99 |
| 10 | 2022 - Q4 (2022-12-31) | $7,379,400 | 2.19% | 210,000 | $33.31 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
613.0000:500.0000 on 2022-07-22
-
4.0000:5.0000 on 2022-07-19